Homeopathic medicine and covid-19 pandemic: a prospective cohort study in Rio de Janeiro

Phase 1

• Conditions: COVID-19; C01.748

• Registration Number: RBR-5vzynf3
• Lead Sponsor: Faculdade de Farmácia da Universidade Federal do Rio de Janeiro

Brief Summary

Data from 51 families (128 participants) were analyzed and showed no statistically significant difference related to the severity of illness in the previous sick and health groups. Although, the secondary outcome showed that a high percentage of the participants (98.03%) reported having had general health symptoms' improvements (84.31%) and none reported adverse events. Despite the previous comorbidities in 52.9% of the families and considering that Covid-19 infected 1.96% of them, only 0.098% looked for medical assistance and none needed hospitalization.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2020-07-31
• Study Start: 2023-03-29
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Data analysis completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Women and men aged 18 years or older with or not COVID-19 influenza-like symptoms were included in this study

Exclusion Criteria

The exclusion criterion was a severe acute respiratory syndrome that leads to hospitalization by primary care teams

Study & Design

• Study Type: Intervention
• Study Design: Not specified